Psilocybin-Research.comSearchable psilocybin and psilocin bibliometrics.
Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Baylor College of Medicine

91 indexed publications match this author name.

ORCID
Not found in stored metadata
OpenAlex
Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Publication history

Psilocybin-assisted therapy in treatment-resistant depression: rapid remission, uncertain durability, and the next phase of clinical evidenceAnnals of Medicine and Surgery · 2026-06-17Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in ratsCell Reports Medicine · 2026-05-31A Pilot Mechanistic Study of Psilocybin-Assisted Therapy as a Treatment for DepressionClinicalTrials.gov · 2026-05-19Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. AdultsAmerican Journal of Preventive Medicine · 2026-05-03C29-12 Psilocybin Treatment Could Improve Outcomes for Age-associated Lung DiseasesAmerican Journal of Respiratory and Critical Care Medicine · 2026-04-30India’s Unique Legal Framework for Psilocybin Mushroom Research: An Unprecedented Opportunity in Psychiatric TherapeuticsIndian Journal of Psychological Medicine · 2026-02-04Computational Analysis of Psilocybin Effects on Three-Choice Touchscreen Reversal Learning in Rats: A Pilot StudyPsychedelic Medicine · 2026-02-02PSilocybin for psYCHological and existential distress in PALliative care (PSYCHED-PAL): A single arm unblinded clinical trialPalliative Medicine · 2026-01-29The STARLIGHT Protocol: State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing TraumaClinicalTrials.gov · 2026-01-21Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 StudyPsychedelic Medicine · 2026-01-17Intentions, Spirituality, Set, and Setting Are Associated with Mystical Experiences in Psilocybin-Assisted TherapyPsychedelic Medicine · 2026-01-11Facing Mortality Together: A Constructivist Grounded Theory Analysis of Group Psilocybin Therapy Among Older Long-Term AIDS Survivor Gay MenPalliative Medicine Reports · 2025-12-31‘Shroom’ for concern: a case of psychedelic mushroom-induced acute kidney injuryInternal Medicine Journal · 2025-12-31A Nature-Themed Video Intervention Increases Nature Relatedness in Psilocybin-Assisted Psychotherapy for Alcohol Use DisorderPsychedelic Medicine · 2025-12-25Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 StudyPsychedelic Medicine · 2025-12-22Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic ResearchPsychedelic Medicine · 2025-12-18Psilocybin reporting in media (PRiMe) for the treatment of depressionIrish Journal of Psychological Medicine · 2025-12-17Preadministration of Lorazepam Negates the Long-Term Antidepressant-Like Effects of Psilocybin in Male Wistar Kyoto RatsPsychedelic Medicine · 2025-12-15Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatmentEClinicalMedicine · 2025-11-30Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions: The Great Promise of Psychedelics: Evolving Human ConsciousnessPsychedelic Medicine · 2025-11-30Griffiths et al.’s Study of Psilocybin with Religious Professionals: A Theological Response from a Christian PerspectivePsychedelic Medicine · 2025-11-30Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions, by Griffiths et alPsychedelic Medicine · 2025-11-30Psilocybin, Spirituality, and the Potential for Personal Transformation: Commentary on Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions by Griffiths et alPsychedelic Medicine · 2025-11-30Using Insights from a Study of Psilocybin with Clergy to Advance Research on Psychedelics, Spirituality, and the Sacred: Commentary on Griffiths et al. (2025)Psychedelic Medicine · 2025-11-26Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Disorders: A Scoping ReviewPsychedelic Medicine · 2025-11-23Advancing treatment paradigms: the role of psilocybin in managing major depressive disorderAnnals of Medicine and Surgery · 2025-11-23Precision Functional Brain Mapping to Understand the Mechanisms of PsilocybinClinicalTrials.gov · 2025-10-30Psilocybin as a fast-acting and long-lasting antidepressant for adolescence: Proposing NeuroD1 as a biomarker of its long-term plasticityBiomedicine & Pharmacotherapy · 2025-10-29Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trialPLoS Medicine · 2025-09-18Evolution and Comparative Analysis of Clinical Trials on Psilocybin in the Treatment of Psychopathologies: Trends in the EU and the USJournal of Clinical Medicine · 2025-09-18“To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group TherapyPsychedelic Medicine · 2025-08-24Optimizing Microdosing and MeditationClinicalTrials.gov · 2025-06-04Publisher’s Note re: “Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions” (doi: 10.1089/psymed.2023.0044)Psychedelic Medicine · 2025-05-29Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World ReligionsPsychedelic Medicine · 2025-05-15Investigating the Role of Serotonin in the Mechanism of Action of Psilocybin in Patients With Major Depressive DisorderClinicalTrials.gov · 2025-05-13Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysisThe International Journal of Psychiatry in Medicine · 2025-04-24The Rise of Psilocybin Use in the United States: A Multisource Observational StudyAnnals of Internal Medicine · 2025-04-20Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative CarePalliative Medicine Reports · 2025-04-16Moral Considerations and the Experience of Ego Dissolution: Insights from PsilocybinAsian Journal of Ethics in Health and Medicine · 2024-12-31Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians’ ConcernsThe Journal of Law Medicine & Ethics · 2024-12-31Psilocybin-Assisted Therapy May Enhance Conservation Values in Patients with Alcohol Use DisorderPsychedelic Medicine · 2024-11-24Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II DisorderPsychedelic Medicine · 2024-11-17Amid magic and menace: psychiatrists’ attitudes to psilocybin therapyIrish Journal of Psychological Medicine · 2024-11-06Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialEClinicalMedicine · 2024-09-22Use of Psilocybin in the Treatment of Mental Disorders: Systematic Review of Clinal TrialsJournal of Complementary Medicine & Alternative Healthcare · 2024-09-16Psilocybin-Assisted Therapy for Brain Cancer Related Existential Distress: A Case-ReportJournal of Palliative Medicine · 2024-09-11Acute Effects of Psilocybin and Salvinorin-A on Functional ConnectivityProceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 2024-08-13How psilocybin affects the brainNature Medicine · 2024-07-29Psilocybin for the Treatment of Major Depressive DisorderClinicalTrials.gov · 2024-07-24PTSD Treatment: An Inquiry into the Promising Potential of PsilocybinJournal of Advances in Medicine and Medical Research · 2024-07-23Psilocybin: Medicine for My Soul. Relief from Emotional and Spiritual Pain as a Hospice Nurse Diagnosed with CancerJournal of Palliative Medicine · 2024-06-24Evolving Guidelines for the Use of Touch During a Clinical Trial of Group Psilocybin-Assisted TherapyPsychedelic Medicine · 2024-05-07Psilocybin poisoning from Psilocybe argentipes ingestionVisual Journal of Emergency Medicine · 2024-03-10Impact of Psilocybin on Peripheral Cytokine ProductionPsychedelic Medicine · 2024-02-27Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based surveyPalliative Medicine · 2024-01-21Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depressionPsychological Medicine · 2024-01-21Endocrinology-informed neuroimaging in eating disorders: GLP1, orexins, and psilocybinTrends in Molecular Medicine · 2023-12-18Psilocybin for Opioid Use Disorder in Two Adults Stabilized on Buprenorphine: A Technical Report on Study Modifications and Preliminary FindingsPsychedelic Medicine · 2023-11-30Psilocybin-Assisted Cognitive Behavioral Therapy for Adults with Major Depressive Disorder: Rationale and Treatment DevelopmentPsychedelic Medicine · 2023-09-05Psilocybin Use in Palliative Care #464Journal of Palliative Medicine · 2023-08-31Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy VolunteersPsychedelic Medicine · 2023-08-29Medical Students' Attitudes and Beliefs Toward Psilocybin: Does Terminology and Personal Experience with Psychedelics Matter?Psychedelic Medicine · 2023-08-17Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility StudyJournal of Palliative Medicine · 2023-08-16Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic modelPsychological Medicine · 2023-06-01Personality change in a trial of psilocybin therapy v. escitalopram treatment for depressionPsychological Medicine · 2023-06-01A Single Administration of Psilocybin Persistently Rescues Cognitive Deficits Caused by Adolescent Chronic Restraint Stress Without Long-Term Changes in Synaptic Protein Gene Expression in a Rat Experimental System with Translational Relevance to DepressionPsychedelic Medicine · 2023-02-28SV2A Marker of Synaptogenesis in a Clinical Trial of Psilocybin for DepressionClinicalTrials.gov · 2023-01-29Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trialEClinicalMedicine · 2022-12-27Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.Psychedelic Medicine · 2022-10-27Psilocybin therapy reduces heavy drinking.Nature Medicine · 2022-09-07Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders: Proceedings of a WorkshopNational Academies Press (US), Washington (DC) · 2022-08-31Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response.Biomedicine & Pharmacotherapy · 2022-08-29Psilocybin-Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience.Journal of Personalized Medicine · 2022-06-18Is PTSD an Evolutionary Survival Adaptation Initiated by Unrestrained Cytokine Signaling and Maintained by Epigenetic Change?Military Medicine · 2022-04-20Increased global integration in the brain after psilocybin therapy for depression.Nature Medicine · 2022-04-10Psilocybin increases brain network integration in patients with depression.Nature Medicine · 2022-03-31Case Report: Magic Mushroom (Psilocybe Cubensis) IntoxicationArchives of The Medicine and Case Reports · 2021-10-12Effectiveness of Psilocybin on Depression: A Qualitative StudyElectronic Journal of General Medicine · 2021-04-26Trial of Psilocybin versus Escitalopram for Depression.New England Journal of Medicine · 2021-03-31Unmet need in depression: Psilocybin, a breakthrough treatment optionInternational Journal of Advanced Research in Medicine · 2020-12-31Psilocybin-assisted group therapy: A new hope for demoralizationEClinicalMedicine · 2020-09-30Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot studyEClinicalMedicine · 2020-09-23What Psilocybin Taught Me, One Year LaterJournal of Palliative Medicine · 2020-07-14Rostral Anterior Cingulate Thickness Predicts the Emotional Psilocybin ExperienceBiomedicines · 2020-02-17Is Psilocybin an Effective Treatment to Reduce Depression and Anxiety in Cancer Patients with a Diagnosis of an Anxiety Disorder, Mood Disorder, And/Or Stress Disorder?Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine) · 2019-12-31What Psilocybin Taught Me About Dying.Journal of Palliative Medicine · 2018-11-08Could Hallucinogens Induce Permanent Pupillary Changes in (Ab)users? A Case Report from New Zealand.Case Reports in Neurological Medicine · 2017-08-16Magic Mushroom Growing Kits: A new method for infringement of the narcotic laws.Turkish Journal of Forensic Medicine · 2013-12-31Moral transhumanism: the next step.The Journal of Medicine and Philosophy A Forum for Bioethics and Philosophy of Medicine · 2012-07-31Novel, unifying mechanism for mescaline in the central nervous system: electrochemistry, catechol redox metabolite, receptor, cell signaling and structure activity relationships.Oxidative Medicine and Cellular Longevity · 2009-08-31

Author directory

Carhart-Harris RL.58 publicationsVollenweider FX51 publicationsCarhart-Harris R50 publicationsGriffiths RR50 publicationsNutt DJ49 publicationsJohnson MW44 publicationsErritzoe D42 publicationsRoseman L41 publicationsRobin Carhart-Harris39 publicationsBarrett FS.34 publicationsPreller KH33 publicationsJohns Hopkins University31 publicationsKnudsen GM30 publicationsNutt D28 publicationsHendricks PS27 publicationsDavid Erritzøe25 publicationsRoland R. Griffiths25 publicationsGarcia-Romeu A23 publicationsDavid Nutt22 publicationsFranz X. Vollenweider22 publicationsGitte M. Knudsen22 publicationsPáleníček T.22 publicationsRosenblat JD22 publicationsFisher PM21 publicationsDavis AK20 publicationsDea Siggaard Stenbæk19 publicationsKargbo RB.19 publicationsKatrin H. Preller19 publicationsMcIntyre RS.19 publicationsStenbæk DS19 publicationsTimmermann C19 publicationsDos Santos RG18 publicationsLiechti ME18 publicationsPatrick M. Fisher18 publicationsRoss S18 publicationsYaden DB18 publicationsDeco G17 publicationsDirk Hoffmeister17 publicationsHusain MI17 publicationsKuypers KPC.17 publicationsM. Madsen17 publicationsMatthew W. Johnson17 publicationsSimonsson O17 publicationsTomáš Páleníček17 publicationsKringelbach ML.16 publicationsOzenne B16 publicationsSeifritz E16 publicationsBrice Ozenne15 publicationsFischer R.15 publicationsFrederick S. Barrett15 publicationsGonzález-Maeso J15 publicationsGuy M. Goodwin15 publicationsJoshua D. Rosenblat15 publicationsKettner H15 publicationsKwan AC.15 publicationsMadsen MK15 publicationsMason NL.15 publicationsNichols DE15 publicationsRamaekers JG15 publicationsUniversity Hospital15 publicationsYale University15 publicationsAlbert Garcia-Romeu14 publicationsBogenschutz MP14 publicationsGeyer MA.14 publicationsHalberstadt AL14 publicationsKometer M14 publicationsNayak SM14 publicationsBasel13 publicationsFeilding A13 publicationsGukasyan N.13 publicationsManish Agrawal13 publicationsNathan D. Sepeda13 publicationsSandeep M. Nayak13 publicationsSwitzerland13 publicationsTagliazucchi E13 publicationsGiribaldi B12 publicationsGoldberg SB12 publicationsHallak JEC.12 publicationsHasler F.12 publicationsHoffmeister D12 publicationsJames Rucker12 publicationsLerer B.12 publicationsLiknaitzky P12 publicationsMcCulloch DE12 publicationsRucker J.12 publicationsRucker JJ.12 publicationsYoung AH12 publicationsAgin-Liebes G11 publicationsBenyamina A11 publicationsBouso JC.11 publicationsGouzoulis-Mayfrank E11 publicationsHolze F11 publicationsJoshua Woolley11 publicationsKaelen M11 publicationsMartin Kuchař11 publicationsMuhammad Ishrat Husain11 publicationsNichols CD.11 publicationsOsika W11 publicationsScott T. Aaronson11 publicationsStephen Ross11 publicationsWang X.11 publicationsAnderson BT10 publicationsBarnett BS10 publicationsDavoudian PA10 publicationsErica Kaczmarek10 publicationsHoráček J10 publicationsHouman Farzin10 publicationsKovar KA.10 publicationsMatthias E. Liechti10 publicationsMichael P. Bogenschutz10 publicationsRoger S. McIntyre10 publicationsSchmid Y10 publicationsSchoevers RA10 publicationsUniversity of California10 publicationsVohryzek J10 publicationsZoe Doyle10 publicationsAaronson ST9 publicationsAndrea Mattarei9 publicationsArmand S9 publicationsBotvinnik A9 publications